These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

599 related articles for article (PubMed ID: 2550253)

  • 1. The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor.
    Tricklebank MD; Singh L; Oles RJ; Preston C; Iversen SD
    Eur J Pharmacol; 1989 Aug; 167(1):127-35. PubMed ID: 2550253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo labelling of the NMDA receptor channel complex by [3H]MK-801.
    Price GW; Ahier RG; Middlemiss DN; Singh L; Tricklebank MD; Wong EH
    Eur J Pharmacol; 1988 Dec; 158(3):279-82. PubMed ID: 2472964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the anticonvulsant effects of competitive and non-competitive antagonists of the N-methyl-D-aspartate receptor.
    Nevins ME; Arnolde SM
    Brain Res; 1989 Nov; 503(1):1-4. PubMed ID: 2558775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classification of compounds for prevention of NMDLA-induced seizures/mortality, or maximal electroshock and pentylenetetrazol seizures in mice and antagonism of MK801 binding in vitro.
    Palmer GC; Harris EW; Ray R; Stagnitto ML; Schmiesing RJ
    Arch Int Pharmacodyn Ther; 1992; 317():16-34. PubMed ID: 1456842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of non-competitive NMDA receptor antagonists on rats exposed to hyperbaric pressure.
    Wardley-Smith B; Wann KT
    Eur J Pharmacol; 1989 Jun; 165(1):107-12. PubMed ID: 2548878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anticonvulsant and behavioural profile of L-687,414, a partial agonist acting at the glycine modulatory site on the N-methyl-D-aspartate (NMDA) receptor complex.
    Tricklebank MD; Bristow LJ; Hutson PH; Leeson PD; Rowley M; Saywell K; Singh L; Tattersall FD; Thorn L; Williams BJ
    Br J Pharmacol; 1994 Nov; 113(3):729-36. PubMed ID: 7858861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo characterization of phencyclidine/sigma agonist-mediated inhibition of nociception.
    DeLander GE; Wahl JJ
    Eur J Pharmacol; 1989 Jan; 159(2):149-56. PubMed ID: 2468511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence against an involvement of the haloperidol-sensitive sigma recognition site in the discriminative stimulus properties of (+)-N-allylnormetazocine ((+)-SKF 10,047).
    Singh L; Wong EH; Kesingland AC; Tricklebank MD
    Br J Pharmacol; 1990 Jan; 99(1):145-51. PubMed ID: 2158832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a role of the N-methyl-D-aspartate (NMDA) receptor in cortical spreading depression in the rat.
    Marrannes R; Willems R; De Prins E; Wauquier A
    Brain Res; 1988 Aug; 457(2):226-40. PubMed ID: 2851364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the discriminative stimulus produced by phencyclidine due to an interaction with N-methyl-D-aspartate receptors?
    Jackson A; Sanger DJ
    Psychopharmacology (Berl); 1988; 96(1):87-92. PubMed ID: 2906445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pentobarbital-like discriminative stimulus effects of N-methyl-D-aspartate antagonists.
    Willetts J; Balster RL
    J Pharmacol Exp Ther; 1989 May; 249(2):438-43. PubMed ID: 2542531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of competitive and noncompetitive N-methyl-D-aspartate (NMDA) antagonists in rats trained to discriminate NMDA from saline.
    Willetts J; Balster RL
    J Pharmacol Exp Ther; 1989 Nov; 251(2):627-33. PubMed ID: 2553930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist.
    Wong EH; Kemp JA; Priestley T; Knight AR; Woodruff GN; Iversen LL
    Proc Natl Acad Sci U S A; 1986 Sep; 83(18):7104-8. PubMed ID: 3529096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys.
    Koek W; Woods JH; Winger GD
    J Pharmacol Exp Ther; 1988 Jun; 245(3):969-74. PubMed ID: 2838610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticonvulsant and behavioral effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine.
    Löscher W; Hönack D
    J Pharmacol Exp Ther; 1991 Feb; 256(2):432-40. PubMed ID: 1671593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of phencyclidine and other N-methyl-D-aspartate antagonists on the schedule-controlled behavior of rats.
    Sanger DJ; Jackson A
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1215-21. PubMed ID: 2649656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [3H]MK-801 labels a site on the N-methyl-D-aspartate receptor channel complex in rat brain membranes.
    Wong EH; Knight AR; Woodruff GN
    J Neurochem; 1988 Jan; 50(1):274-81. PubMed ID: 2826686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dextromethorphan inhibits NMDA-induced convulsions.
    Ferkany JW; Borosky SA; Clissold DB; Pontecorvo MJ
    Eur J Pharmacol; 1988 Jun; 151(1):151-4. PubMed ID: 3046955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative electroencephalographic and behavioral effects of phencyclidine, (+)-SKF-10,047 and MK-801 in rats.
    Marquis KL; Paquette NC; Gussio RP; Moreton JE
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1104-12. PubMed ID: 2557412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitive and rapid behavioral differentiation of N-methyl-D-aspartate receptor antagonists.
    Ginski MJ; Witkin JM
    Psychopharmacology (Berl); 1994 May; 114(4):573-82. PubMed ID: 7855218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.